Nevertheless, the results of multivariate Cox regression model suggested that the activity of FOXM1 in MDA-MB-231 cell line, proliferation activity, still is an independent biomarker in breast cancer sample prognosis (see Supplementary Table 3). This evidence concerns the gene FOXM1 and breast cancer.